chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PANIC ATTACKS(DIZZINESS, WHOLE BODY TREMBLING, RACING HEART RATE, DIFFICULTY BREATHING); HEART RATE 175 BPM; BRAIN FOG; This spontaneous report received from a patient concerned a 35 old female. The patient's height, and weight were not reported. The patient's concurrent conditions included latex allergy, and other pre-existing medical conditions included the patient did not have any history of anxiety.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, one total administered on 05-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date in APR-2021 it was stated that the patient experienced something similar to panic attacks only while driving, brain fog, lightheadedness, dizziness, whole body was trembling and racing heart of 175 BPM, patient took about 2 hours to get heart rate down. On same day the friend drove her to hospital because she was lightheaded and needed to get help getting in car. Patient received vitals and fluids in hospital and her blood report was normal. ON 11-Apr-2021, after 10 -15 minutes into driving patient felt lightheadedness and dizziness again and felt like she couldn't breathe. It was stated by the patient that motion seems to trigger because it happens while driving. Patient had to take deep breaths for 1.5 hours to get her heart rate down. Laboratory data included: Blood test (NR: not provided) Normal, and Heart rate (NR: not provided) 175 BPM. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from panic attacks (dizziness, whole body trembling, racing heart rate, difficulty breathing), brain fog, and heart rate 175 bpm. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210421092-JANSSEN COVID-19 VACCINE Ad26.COV2.S- Panic attacks, Heart rate 175 BPM, Brain fog. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Patient received vax Nov/10/97. 2 days later patient presented to the ER and was dx with cellulitis of the left arm.
Vaccine was administered in accordance with standard procedures, subcutaneously in the Left arm over the triceps muscle on May 15, 2007. On May 20, the patient developed a painful, red, blistering rash involving the Left T-7/8 dermatome. He contacted me on ~May 24 and was treated with Famcyclovir 500mg three times daily for one week. Given the timing, the patient is convinced that the vaccine caused his Zoster-like illness.
no adverse event; the patient was administered one dose ofMMR II (lot number N026273, expiration date 9/21/2019) on 6/12/2019 and then was inadvertently administered the second dose of MMR-II (lot number N026273, expiration date 9/21/2019) two-weeks after the first do; This spontaneous report was received from a nurse and concerned to a 46 year old patient of unknown gender.  The patient's historical condition, concomitant medications and drug reactions or allergies were not reported   On 12-JUN-2019, the patient was vaccinated with the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # N026273 and expiration date 21-SEP-2019, subdermal for prophylaxis (dosage schedule, route, and anatomical location were not reported) .         On 01-JUL-2019 (reported as two weeks after the first dose), the patient was inadvertently administered with a the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (inappropriate schedule of product administration) lot # N026273 and expiration date 21-SEP-2019, subdermal for prophylaxis (dosage schedule, route, and anatomical location were not reported) .   The outcome of inappropriate schedule of product administration and no adverse event was unknown.
Pt received PENTACEL 7/8/15 to left thigh - 7/10/15 to ER with redness, swelling at injection site. TX allergic rxn and cellulitis.
titers for measles were low; This spontaneous report was received from a nurse and refers to a 58-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date, as a child, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection for prophylaxis (dose, route of administration, injection site, lot # and expiration date were not reported). On an unknown date, the patient's titers for measles were low(exact results were not provided). The outcome the event was unknown. The relatedness between the event and the suspect product was not provided.
headache and dizziness intermittently; headache and dizziness intermittently; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (headache and dizziness intermittently) and HEADACHE (headache and dizziness intermittently) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Pre-diabetic.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (headache and dizziness intermittently) and HEADACHE (headache and dizziness intermittently). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (headache and dizziness intermittently) and HEADACHE (headache and dizziness intermittently) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Spine issues are the other medical history reported by reporter. Action taken with mRNA-1273 in response to the events was not Applicable.
Patient states 2-3 days after H1N1 injection - Began getting dizzy spells. Seem to come and go. Is sched. for eval. today since not getting better.
Reports fever evening of vaccination and tenderness to injection site.  Reports that tenderness wore off and developed red rash to left arm extending down bicep. No pain, no swelling, no ecchymosis, no tenderness to touch.   Area is warm to touch, afebrile, normal HR in clinic, denies fevers, chills,   Reports occasional itch to area, denies that redness is extending past original markings.
I had a sore throat for two days that progressed to cough with mucus. It went into my sinuses, I took MUCINEX to help clear up the mucus drainage. The cough seems to be lingering but is better and I still have some congestion. I took a home COVID-19 test on Friday, it came back negative. I went to my doctor's office that same morning to have PCR COVID-19 test done and I am awaiting the results.
Dysmenorrhoea; Medication Error. This case was reported by a nurse and described the occurrence of dysmenorrhea in a 19 year old female patient who received hepatitis A vaccine inactivated (Havrix). On an unspecified date, the subject inadvertently received the pediatric dosage of Havrix for her first injection in the immunization series. Two days post-immunization, the subject traveled by airplane without having had fluids or breakfast. She then presented to an emergency room with complaints of back pain, nausea, blood in her urine, loose stools, sudden onset of dizziness, pre-syncope and weakness. The emergency room physician made a diagnosis of dysmenorrhea. The vaccine provider "thinks Havrix may have had some role in the series of events".
SOB, COUGH, LOST OF TASTE, DIARRHEA, GENERAL MALAISE
Given nasal H1N1 influenza vaccine by mistake. No treatment needed, follow up call revealed no ill effects.
Difficulty breathing after receiving seasonal flu mist and H1N1 shot.  Required 3x hospital visits.  Received 2x breathing treatments, prescribed rescue inhaler and steriods for broch. spasms 11/24 and 12/4/2009 ED records for 11/18/2009, Dx acute Bronchitis patient with c/o's SOB, chest pain. Tx: resp tx's with nebs
Face got red about 15 minutes after shot. EMT came. Blood pressure elevated but went down and was declared stable. About 15 minutes took a Benadryl. About 15 redness began to recede and in a half an hour it was gone.
rash on left armpit and left leg raised irritated red spot at injection site larger than a silver dollar Treated with Allegra Sunday and Monday -  Is  improving.  Called the pediatrican Tuesday 1/25 who asked that I complete this form
Hospitalized with frequent falls also COVID positive in August which would have been reported as Temporary report number: 617410
1-2 days after vaccination patient started with erythema around the nose, rhinorrhea and itchy rash of nose. Then on 11/20-11/21 noted some slight facial swelling, cheeks and below the eye. Seen at PCP office 11/21/2022 noted to have mild facial edema without angioedema. No diffuse urticaria, airway not compromised. given antihistamines and topical steroid cream for rash.
The entire thigh of the left leg was swollen, very red and warm to the touch.  Less severe similar reaction on the right thigh.  Baby was also visibly upset and in pain based on his reactions to touching the area or moving the muscle in any way.  Baby received warm bath since he was visibly upset when warm compresses were attempted.  Bath seemed to calm baby.  An hour later area was still swollen, but less red.  Mom took pictures for documentation.  Around 3:30 pm baby developed low grade fever which ranged from 99.4-100.5 up until bed time.  Mom nursed baby on demand to ensure plenty of fluids were being received and wet/dirty diapers were monitored as well.  Baby continued to be monitored for any additional symptoms.  The following morning (4/21/15), the baby's fever was gone as was all redness.  As of this reporting, both thighs are still slightly swollen, there is bruising at both injection sites and in the right thigh there is a blueberry sized hard lump in the muscle.  Mom plans to massage the thigh in another warm bath today (4/21/15).
Pt called office 3/29/12 c/o dry cough, heaviness in chest. Symptoms started yesterday (day she got PNUEMOVAX 23). Advised MUCINEX DM, declines OV. 3/30/12, increased SOB, fever about 101 degrees, hoarse, body aches, fatigue. Declines OV. Dr reviewed chart. Rec: TYLENOL prn, DC MUCINEX, BENADRYL qhs 4-10-12 pt. feeling better. Some fatigue . Dry cough.
first shot for Shingrix one year ago and not received 2nd dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st shot received one year ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The reporter asked what was the recommendation when a customer received the 1st shot for Shingrix one year ago from the date of reporting, the patient did not received 2nd dose of Shingrix till the time of reporting which led to incomplete course of vaccination. No contact details were available.
Narrative:  91yo male patient died at Hospital PALLIATIVE UNIT on 10/9/21. Pt with recurrent malignant neoplasm of prostate, DM, HTN, dementia, GERD, tremor, hypothyroid. Pt had received covid vaccines on 1/22/21 & 2/22/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Covid vaccine monitoring documentation: PT admission 1/22/22 - 1/26/2022.   COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose (PFIZER) 09/09/2021 30135BA.  COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose (PFIZER) 10/01/2021 30145BA
Muscle spasms and shooting pains in neck on left side, and shoulders, arms, and legs bilaterally. Chills, malaise.
30 min. after vaccines administered patient developed hives on trunk, arms, chin, neck. No edema, no SOB
Information has been received from a pharmacist concerning an elderly pt who in approx. 10/01, was vaccinated with pneumococcal vaccine 23 polyvalent. The pharmacist reported that a few days after vaccination, a CXR showed infiltrate. The pt had sought medical attention for his  experience. Additional information has been requested.
Initial report received from a healthcare professional who is also the patient on 15 February 2013. A male patient (age and date of birth were not reported), had received a dose of FLUZONE (batch number: UH746AC, expiry date: 06-30-2013, number in series not reported) intramuscularly in left deltoid on 29 November 2012. The patient also received a dose of BOOSTRIX (manufacturer: GlaxoSmithKline, batch number, number in series, route and site of administration were not reported) on 30 November 2012 (day after FLUZONE administration). The patient had no illness at the time of vaccination and had no pre-existing physician diagnosed allergies, birth defects and medical conditions. The patient's concomitant medications were not reported. On an unspecified date, few days after vaccination the patient developed papules in the elbow area of his right arm, and the patient believed that it was zoster. At the time of this report, the symptoms had improved, but redness to the skin in the area remained. Corrective treatment details were not reported. No laboratory investigations were performed. The patient's outcome was not recovered. Documents held by sender: None.
ended up in the emergency room unable to stand and fall over and broke his nose in ER; Ended up in the emergency room unable to stand and fall over and broke his nose in ER; Unable to stand; This is a spontaneous report from a contactable consumer.  A 34-year-old male patient received BNT162B2 on unspecified date in Apr2021 (at age of 34-year-old) at single dose for COVID-19 immunization. Medical history included ongoing Primary progressive Multiple sclerosis and Hospitalized Flare up. Concomitant medications include fampridine (AMPYRA) from Apr2021 to unspecified date, dimethyl fumarate (TECFIDERA). On unknown date it was reported that patient experienced: ended up in the emergency room unable to stand and fall over and broke his nose in the ER. The outcome of the reported events was unknown.  Information about lot/batch number has been requested.
Patient got nauseous and dizzy approx 10 minutes after administration. BP dropped to approx 75/50. Patient laid down. Benadryl given @ 50mg oral liquid dose, patient requested water bottle which was provided and consumed. EMS arrived and patients BP went to to approx 95/55. Patient became ambulatory and went home.
No adverse effects; one dose of GARDASIL 9 that had expired was inadvertently administered to the patient on 8/21/2019; This spontaneous report was received from a nurse prescriber via company representative, referring to a patient of unknown gender and age. The patient's concurrent condition, pertinent medical history, concomitant therapy and drug reactions/allergies were not reported.  On 21-AUG-2019, the patient was inadvertently vaccinated with one dose of expired hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, frequency and route of administration not reported) (lot #: M037770, expiration date: 01-JUN-2019) (expired product administered) for prophylaxis. No adverse effects were reported.
itchy face started about 3-4 days after vaccine.  Did not think anything of it.  Got significantly worse within 2 days of the second vaccine
PROGRESS NOTE 1/23/2022 68 year old man with hx of cognitive impairment, CVA, remote hx of alcohol abuse, T2DM, and atrial fibrillation on Xarelto who is admitted acute hypoxic respiratory failure secondary to COVID-19 pneumonia. Remains on HFNC.    Acute hypoxic respiratory failure COVID-19 pneumonia CAP Tested positive on 1/13. Vaccinated. Worsening O2 requirements overnight into 1/15. Transferred to ICU on 1/6 for 24 hours.  Then was on HFNC on floor. Procal 2.8 so treated for superimposed CAP as well w/ azithro/ceftriaxone (abx complete as of 1/20)   As of 1/20 Currently on 50 LPM 90% FiO2. WBC downtrending.   1/21 on 55L at 90%FIO2, however appears comfortable and not in distress. CRP trending down to 0.9    1/23 Pt improving considerably, down to 7L by facemask. CRP trended to 0.7   - Wean O2 as able to goal O2 >92% - switch from solumedrol to decadron 6mg daily - on Xarelto for AC for atrial fibrillation - incentive spirometer -ok to stop trending DDIMER, CRP   Diabetes Mellitus type 2 Steroid-induced hyperglycemia     BS in 300s on 1/23 likely steriod induced - Discussed insulin with PharmD, will adjust to NPH 26u BID,  -anticipate being able to decrease insulin as steriods parse down -PharmD to follow - Hold PTA dulaglutide and sitagliptin-metformin while in house; Hgb A1c 8.1 - MDSSI   Goals of care Per sister, goals are restorative, but understanding that this is based on a similar quality of life that he has now. Given baseline cognitive status and current deconditioning, patient is not likely to have a favorable outcome if needing intubation. Would benefit from discussing this further. Additionally, she would appreciate assistance with filling out his advance directives if nearing discharge as well.  - palliative consulted, appreciate recs   Hyperkalemia 2/2 hemolyzed samples, resolved K 6.7 (hemolyzed) recheck 4.8. Reoccured multiple times. Noted to be hemolyzed when pulled off PICC.    K of 5.0 on 1/23 - communicated with RNs, will not pull K samples off PICC   Atrial fibrillation Rate controlled in 70s. EKG from 1/18 read as STEMI however given patient is paced spoke with cardiology and this is not interpretable - Continue PTA Xarelto   Fall No significant injury. Suspect related to hypoxia and associated generalized weakness.  - PT and OT consulted   Cognitive impairment Appears to be at baseline mental status. He reports that he is his own decision maker. No guardian listed on paperwork from group home.  - Continue PTA asa 81 mg - Continue PTA atorvastatin 40 mg - Continue PTA sertraline 50 daily   Hard of hearing - Normally wears hearing aids.  Normocytic Anemia - Hgb in 11s. No signs or symptoms of acute bleed.  Acute kidney injury, resolved -Cr elevated to 1.27 from 0.93. Urine lytes obtained on 1/14 and FeNA 0.2%, consistent with prerenal etiology. Improved in AM of 1/15 to 0.9. Tobacco use disorder - Continue PTA nicotine patch
Started with fever - 101.6 (tympanic) per mom.  Gave infant Tylenol.  Acting pleasant, feeling well.
Can't feel bones from hips to lower tibia.; Stand for 10 minutes and has to sit down; can't feel bones from hips to lower tibia, pain in the knee joint; running a temp, like having covid; Body aches; No appetite; Sore throat; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), OROPHARYNGEAL PAIN (Sore throat), DISCOMFORT (Can't feel bones from hips to lower tibia.), DYSSTASIA (Stand for 10 minutes and has to sit down) and ARTHRALGIA (can't feel bones from hips to lower tibia, pain in the knee joint) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005c21a, 039k202a and 012l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was not provided.  Concomitant products included METFORMIN HYDROCHLORIDE (MEDFORMIN) and METOPROLOL for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Nov-2021, the patient experienced DECREASED APPETITE (No appetite), OROPHARYNGEAL PAIN (Sore throat) and MYALGIA (Body aches). On 17-Nov-2021, the patient experienced DISCOMFORT (Can't feel bones from hips to lower tibia.), DYSSTASIA (Stand for 10 minutes and has to sit down), ARTHRALGIA (can't feel bones from hips to lower tibia, pain in the knee joint) and PYREXIA (running a temp, like having covid). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 17-Nov-2021, DECREASED APPETITE (No appetite), OROPHARYNGEAL PAIN (Sore throat) and MYALGIA (Body aches) had resolved. At the time of the report, DISCOMFORT (Can't feel bones from hips to lower tibia.), DYSSTASIA (Stand for 10 minutes and has to sit down), ARTHRALGIA (can't feel bones from hips to lower tibia, pain in the knee joint) and PYREXIA (running a temp, like having covid) outcome was unknown.            Patient had never had any problems after the first and second dose.
adverse reaction: within minutes felt faint and dizzy, deep pain in neck, heart rate went up, fullness in lips and tingling, face underskin felt swollen, pressure on side of neck,
chills, hot flashes that have persisted for more than 2 days, extremely hot/sweaty, constant headache/soreness at injection site.
Swollen lymph nodes (size of an orange); high fever; This is a spontaneous report from a contactable physician via Pfizer sales representative.  A patient of an unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), at an unknown route, dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced swollen lymph nodes (size of an orange) and high fever. The outcome of events was unknown.  Follow-up attempts completed. No further information expected.
Information has been received from a office manager and a physician assistant concerning a 36 year old female who on 21-JAN-2009 was vaccinated with PNEUMOVAX 23 (lot number 660685/0619X, route and site not reported). Subsequently the patient developed fever, redness in the arm where the vaccine was given. The physician assistant stated that the patient's "entire arm was swollen". Additional information was received via a telephone call from a physician with no new information about this patient. Follow up information was received from a physician. The physician reported that the patient was vaccinated with her first dose of PNEUMOVAX 23 IM into her left deltoid. On 21-JAN-2009 the patient developed cough, soreness and numbness in whole arm and swelling. The patient required doctor visit. There was no illness at time of vaccination. Outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Patient received vaccine and immediately after lost consciousness.  She did not display an allergic reaction and was checked by paramedics. She fainted with no other symptoms
Pt received in observation post pfizer dose 1 vaccination, 20 minutes into his observation pt stated felt nausea, and I assisted him to cot. Pt stated felt better laying down and after sitting up to drink juice pt reported dizziness. Vital signs taken: bp 120/80, pulse 02 100%, pulse 60 Pt returned to lying position and reported feeling better.  Pt stated thought juice had helped and wanted crackers which he also said made him feel better and felt he could sit up now. Pt sat up and felt fine and vs taken bp 110/70, pulse 02 97%, pulse 60 Pt joined awaiting family and said felt well to leave and RN reviewed discharge ed re IZ side effects and ER  precautions and pt and guardian verbalize understanding.